Product Information
ELIQUIS 5 MG TABLET is a brand product labeled by E.R. Squibb & Sons, L.L.C., priced at $5.5211 per EA under NDC 00003089470. Its NADAC has been published 472 times since Aug 9, 2017.
FDA first approved this application on Dec 28, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
E.R. Squibb & Sons, L.L.C.NDC
00003089470
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
APIXABANApproval Type
New Drug (NDA)
FDA Application
NDA202155FDA Approved
12/28/2012
TE Code
AB
On Market Since
12/28/2012
Pharmacological Classes
Price Statistics
The NADAC for ELIQUIS 5 MG TABLET has been published 472 times since Aug 9, 2017, and over the history we have for it it has declined 11.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.5211 per EA |
|---|---|
| All-time high | $9.7008 (May 14, 2025) |
| All-time low | $5.5211 (Aug 19, 2026) |
| 52-week high | $9.6955 |
| 52-week low | $5.5211 |
| Median price | $7.9842 |
| Average price | $7.9695 |
| Largest weekly change | -43.0% (Jan 14, 2026) |
| Weeks tracked | 472 |
| Tracking since | Aug 9, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ELIQUIS 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ELIQUIS 5 MG TABLET, manufactured by E.R. Squibb & Sons, L.L.C., is $5.5211 per EA (NDC 00003089470), effective Aug 19, 2026.
How has the price of ELIQUIS 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ELIQUIS 5 MG TABLET has declined 11.1%. It has been tracked across 472 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for ELIQUIS 5 MG TABLET?
Since Aug 9, 2017, the NADAC for ELIQUIS 5 MG TABLET has ranged from a low of $5.5211 (Aug 19, 2026) to a high of $9.7008 (May 14, 2025), with a median of $7.9842 per EA.
Are there cheaper alternatives to ELIQUIS 5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ELIQUIS 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ELIQUIS 5 MG TABLET?
ELIQUIS 5 MG TABLET (NDC 00003089470) is labeled by E.R. Squibb & Sons, L.L.C., and CMS classifies it as a brand product.